Induction of mucosal immunity through systemic immunization: Phantom or reality?

References

• Brandtzaeg P, Pabst R. Let's go mucosal: communication on slippery ground. Trends Immunol 2004; 25:570-7; PMID:15489184; http://dx.doi.org/10.1016/j.it.2004.09.005
   PubMed Web of Science ®Google Scholar
• Czerkinsky C, Holmgren J. Mucosal delivery routes for optimal immunization: targeting immunity to the right tissues. Curr Top Microbiol Immunol 2012; 354:1-18; PMID:21053117
   PubMed Web of Science ®Google Scholar
• Bouvet JP, Decroix N, Pamonsinlapatham P. Stimulation of local antibody production: parenteral or mucosal vaccination? Trends Immunol 2002; 23:209-13; PMID:11923116; http://dx.doi.org/10.1016/S1471-4906(02)02186-5
   PubMed Web of Science ®Google Scholar
• Holmgren J, Czerkinsky C. Mucosal immunity and vaccines. Nat Med 2005; 11:S45-53; PMID:15812489; http://dx.doi.org/10.1038/nm1213
   PubMed Web of Science ®Google Scholar
• Parr EL, Parr MB. Immunoglobulin G is the main protective antibody in mouse vaginal secretions after vaginal immunization with attenuated herpes simplex virus type 2. J Virol 1997; 71:8109-15; PMID:9343160
   PubMed Web of Science ®Google Scholar
• Brandtzaeg P. Mucosal immunity: induction, dissemination, and effector functions. Scand J Immunol 2009; 70:505-15; PMID:19906191; http://dx.doi.org/10.1111/j.1365-3083.2009.02319.x
   PubMed Web of Science ®Google Scholar
• Brandtzaeg P. Induction of secretory immunity and memory at mucosal surfaces. Vaccine 2007; 25:5467-84; PMID:17227687; http://dx.doi.org/10.1016/j.vaccine.2006.12.001
   PubMed Web of Science ®Google Scholar
• Berneman A, Belec L, Fischetti VA, Bouvet JP. The specificity patterns of human immunoglobulin G antibodies in serum differ from those in autologous secretions. Infect Immun 1998; 66:4163-8; PMID:9712763
   PubMed Web of Science ®Google Scholar
• Bouvet JP, Fischetti VA. Diversity of antibody-mediated immunity at the mucosal barrier. Infect Immun 1999; 67:2687-91; PMID:10338470
   PubMed Web of Science ®Google Scholar
• Mbawuike IN, Pacheco S, Acuna CL, Switzer KC, Zhang Y, Harriman GR. Mucosal immunity to influenza without IgA: an IgA knockout mouse model. J Immunol 1999; 162:2530-7; PMID:10072492
   PubMed Web of Science ®Google Scholar
• Lambert PH, Laurent PE. Intradermal vaccine delivery: will new delivery systems transform vaccine administration? Vaccine 2008; 26:3197-208; PMID:18486285; http://dx.doi.org/10.1016/j.vaccine.2008.03.095
   PubMed Web of Science ®Google Scholar
• Nochi T, Yuki Y, Takahashi H, Sawada S, Mejima M, Kohda T, Harada N, Kong IG, Sato A, Kataoka N, et al. Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines. Nat Mater 2010; 9:572-8; PMID:20562880; http://dx.doi.org/10.1038/nmat2784
   PubMed Web of Science ®Google Scholar
• Mutsch M, Zhou W, Rhodes P, Bopp M, Chen RT, Linder T, Spyr C, Steffen R. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N Engl J Med 2004; 350:896-903; PMID:14985487; http://dx.doi.org/10.1056/NEJMoa030595
   PubMed Web of Science ®Google Scholar
• Yuki Y, Kiyono H. New generation of mucosal adjuvants for the induction of protective immunity. Rev Med Virol 2003; 13:293-310; PMID:12931340; http://dx.doi.org/10.1002/rmv.398
   PubMed Web of Science ®Google Scholar
• Esposito S, Montinaro V, Groppali E, Tenconi R, Semino M, Principi N. Live attenuated intranasal influenza vaccine. Hum Vaccin Immunother 2012; 8:76-80; PMID:22251995; http://dx.doi.org/10.4161/hv.8.1.18809
   PubMed Web of Science ®Google Scholar
• Ivanov AP, Dragunsky EM, Chumakov KM. 1,25-dihydroxyvitamin d3 enhances systemic and mucosal immune responses to inactivated poliovirus vaccine in mice. J Infect Dis 2006; 193:598-600; PMID:16425140; http://dx.doi.org/10.1086/499970
   PubMed Web of Science ®Google Scholar
• Sheldrake RF, Romalis LF, Saunders MM. Serum and mucosal antibody responses against Mycoplasma hyopneumoniae following intraperitoneal vaccination and challenge of pigs with M hyopneumoniae. Res Vet Sci 1993; 55:371-6; PMID:8284503; http://dx.doi.org/10.1016/0034-5288(93)90110-2
   PubMed Web of Science ®Google Scholar
• Moreno-Fierros L, Garcia N, Gutierrez R, Lopez-Revilla R, Vazquez-Padron RI. Intranasal, rectal and intraperitoneal immunization with protoxin Cry1Ac from Bacillus thuringiensis induces compartmentalized serum, intestinal, vaginal and pulmonary immune responses in Balb/c mice. Microbes Infect 2000; 2:885-90; PMID:10962271; http://dx.doi.org/10.1016/S1286-4579(00)00398-1
   PubMed Web of Science ®Google Scholar
• Rojas-Hernandez S, Rodriguez-Monroy MA, Lopez-Revilla R, Resendiz-Albor AA, Moreno-Fierros L. Intranasal coadministration of the Cry1Ac protoxin with amoebal lysates increases protection against Naegleria fowleri meningoencephalitis. Infect Immun 2004; 72:4368-75; PMID:15271892; http://dx.doi.org/10.1128/IAI.72.8.4368-4375.2004
   PubMed Web of Science ®Google Scholar
• Gai WW, Zhang Y, Zhou DH, Chen YQ, Yang JY, Yan HM. PIKA provides an adjuvant effect to induce strong mucosal and systemic humoral immunity against SARS-CoV. Virol Sin 2011; 26:81-94; PMID:21468931; http://dx.doi.org/10.1007/s12250-011-3183-z
   PubMedGoogle Scholar
• Rodriguez A, Troye-Blomberg M, Lindroth K, Ivanyi J, Singh M, Fernandez C. B- and T-cell responses to the mycobacterium surface antigen PstS-1 in the respiratory tract and adjacent tissues. Role of adjuvants and routes of immunization. Vaccine 2003; 21:458-67; PMID:12531644; http://dx.doi.org/10.1016/S0264-410X(02)00478-4
   PubMed Web of Science ®Google Scholar
• Hodge LM, Simecka JW. Role of upper and lower respiratory tract immunity in resistance to Mycoplasma respiratory disease. J Infect Dis 2002; 186:290-4; PMID:12134269; http://dx.doi.org/10.1086/341280
   PubMed Web of Science ®Google Scholar
• Lue C, van den Wall BA, Prince SJ, Julian BA, Tseng ML, Radl J, Elson CO, Mestecky J. Intraperitoneal immunization of human subjects with tetanus toxoid induces specific antibody-secreting cells in the peritoneal cavity and in the circulation, but fails to elicit a secretory IgA response. Clin Exp Immunol 1994; 96:356-63; PMID:8187345; http://dx.doi.org/10.1111/j.1365-2249.1994.tb06567.x
   PubMed Web of Science ®Google Scholar
• Rodriguez A, Rottenberg M, Tjarnlund A, Fernandez C. Immunoglobulin A and CD8 T-cell mucosal immune defenses protect against intranasal infection with Chlamydia pneumoniae. Scand J Immunol 2006; 63:177-83; PMID:16499570; http://dx.doi.org/10.1111/j.1365-3083.2006.01725.x
   PubMed Web of Science ®Google Scholar
• Heurtault B, Gentine P, Thomann JS, Baehr C, Frisch B, Pons F. Design of a liposomal candidate vaccine against Pseudomonas aeruginosa and its evaluation in triggering systemic and lung mucosal immunity. Pharm Res 2009; 26:276-85; PMID:18781377; http://dx.doi.org/10.1007/s11095-008-9724-y
   PubMed Web of Science ®Google Scholar
• Lu B, Huang Y, Huang L, Li B, Zheng Z, Chen Z, Chen J, Hu Q, Wang H. Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice. Immunology 2010; 130:254-61; PMID:20406307; http://dx.doi.org/10.1111/j.1365-2567.2010.03231.x
   PubMed Web of Science ®Google Scholar
• Shuttleworth G, Eckery DC, Awram P. Oral and intraperitoneal immunization with rotavirus 2/6 virus-like particles stimulates a systemic and mucosal immune response in mice. Arch Virol 2005; 150:341-9; PMID:15578236; http://dx.doi.org/10.1007/s00705-004-0447-z
   PubMed Web of Science ®Google Scholar
• Buonaguro L, Visciano ML, Tornesello ML, Tagliamonte M, Biryahwaho B, Buonaguro FM. Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles administered by different routes of inoculation. J Virol 2005; 79:7059-67s; PMID:15890945; http://dx.doi.org/10.1128/JVI.79.11.7059-7067.2005
   PubMed Web of Science ®Google Scholar
• Nicolas JF, Guy B. Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice. Expert Rev Vaccines 2008; 7:1201-14; PMID:18844594; http://dx.doi.org/10.1586/14760584.7.8.1201
   PubMed Web of Science ®Google Scholar
• Jones T, Adamovicz JJ, Cyr SL, Bolt CR, Bellerose N, Pitt LM, Lowell GH, Burt DS. Intranasal Protollin/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection. Vaccine 2006; 24:1625-32; PMID:16243411; http://dx.doi.org/10.1016/j.vaccine.2005.09.052
   PubMed Web of Science ®Google Scholar
• Santillan DA, Andracki ME, Hunter SK. Protective immunization in mice against group B streptococci using encapsulated C5a peptidase. Am J Obstet Gynecol 2008; 198:111-4.
   Web of Science ®Google Scholar
• EL-Malky MA, Al-Harthi SA, Mohamed RT, EL BM, Saudy NS. Vaccination with Toxoplasma lysate antigen and CpG oligodeoxynucleotides: comparison of immune responses in intranasal versus intramuscular administrations. Parasitol Res 2014; 113:2277-84; PMID:24728558; http://dx.doi.org/10.1007/s00436-014-3882-0
   PubMed Web of Science ®Google Scholar
• Vilte DA, Larzabal M, Garbaccio S, Gammella M, Rabinovitz BC, Elizondo AM, Cantet RJ, Delgado F, Meikle V, Cataldi A, et al. Reduced faecal shedding of Escherichia coli O157:H7 in cattle following systemic vaccination with gamma-intimin C(2)(8)(0) and EspB proteins. Vaccine 2011; 29:3962-8; PMID:21477674; http://dx.doi.org/10.1016/j.vaccine.2011.03.079
   PubMed Web of Science ®Google Scholar
• Haan L, Verweij WR, Holtrop M, Brands R, van Scharrenburg GJ, Palache AM, Agsteribbe E, Wilschut J. Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity. Vaccine 2001; 19:2898-907; PMID:11282201; http://dx.doi.org/10.1016/S0264-410X(00)00556-9
   PubMed Web of Science ®Google Scholar
• Jia R, Guo JH, Fan MW, Bian Z, Chen Z, Fan B, Yu F, Xu QA. Immunogenicity of CTLA4 fusion anti-caries DNA vaccine in rabbits and monkeys. Vaccine 2006; 24:5192-200; PMID:16675075; http://dx.doi.org/10.1016/j.vaccine.2006.03.090
   PubMed Web of Science ®Google Scholar
• Taylor G, Bruce C, Barbet AF, Wyld SG, Thomas LH. DNA vaccination against respiratory syncytial virus in young calves. Vaccine 2005; 23:1242-50; PMID:15652666; http://dx.doi.org/10.1016/j.vaccine.2004.09.005
   PubMed Web of Science ®Google Scholar
• Yang K, Wang S, Chang KO, Lu S, Saif LJ, Greenberg HB, Brinker JP, Herrmann JE. Immune responses and protection obtained with rotavirus VP6 DNA vaccines given by intramuscular injection. Vaccine 2001; 19:3285-91; PMID:11312027; http://dx.doi.org/10.1016/S0264-410X(00)00543-0
   PubMed Web of Science ®Google Scholar
• Perrone LA, Ahmad A, Veguilla V, Lu X, Smith G, Katz JM, Pushko P, Tumpey TM. Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge. J Virol 2009; 83:5726-34; PMID:19321609; http://dx.doi.org/10.1128/JVI.00207-09
   PubMed Web of Science ®Google Scholar
• Huo Z, Bissett SL, Giemza R, Beddows S, Oeser C, Lewis DJ. Systemic and mucosal immune responses to sublingual or intramuscular human papilloma virus antigens in healthy female volunteers. Plos One 2012; 7:e33736; PMID:22438987; http://dx.doi.org/10.1371/journal.pone.0033736
   PubMed Web of Science ®Google Scholar
• Nardelli-Haefliger D, Wirthner D, Schiller JT, Lowy DR, Hildesheim A, Ponci F, De Grandi P. Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles. J Natl Cancer Inst 2003; 95:1128-37; PMID:12902442; http://dx.doi.org/10.1093/jnci/djg018
   PubMed Web of Science ®Google Scholar
• Joo HM, He Y, Sundararajan A, Huan L, Sangster MY. Quantitative analysis of influenza virus-specific B cell memory generated by different routes of inactivated virus vaccination. Vaccine 2010; 28:2186-94; PMID:20056191; http://dx.doi.org/10.1016/j.vaccine.2009.12.058
   PubMed Web of Science ®Google Scholar
• Van Herck K, Crasta PD, Messier M, Hardt K, Van Damme P. Seventeen-year antibody persistence in adults primed with two doses of an inactivated hepatitis A vaccine. Hum Vaccin Immunother 2012; 8:323-7; PMID:22327499; http://dx.doi.org/10.4161/hv.18617
   PubMed Web of Science ®Google Scholar
• Andre F, Van Damme P, Safary A, Banatvala J. Inactivated hepatitis A vaccine: immunogenicity, efficacy, safety and review of official recommendations for use. Expert Rev Vaccines 2002; 1:9-23; PMID:12908508; http://dx.doi.org/10.1586/14760584.1.1.9
   PubMedGoogle Scholar
• Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337:1733-45; PMID:9392700; http://dx.doi.org/10.1056/NEJM199712113372406
   PubMed Web of Science ®Google Scholar
• Michel ML, Tiollais P. Hepatitis B vaccines: protective efficacy and therapeutic potential. Pathol Biol (Paris) 2010; 58:288-95; PMID:20382485; http://dx.doi.org/10.1016/j.patbio.2010.01.006
   PubMed Web of Science ®Google Scholar
• Grassly NC. Immunogenicity and effectiveness of routine immunization with 1 or 2 doses of inactivated poliovirus vaccine: systematic review and meta-analysis. J Infect Dis 2014; 210 Suppl 1:S439-46; PMID:24634499; http://dx.doi.org/10.1093/infdis/jit601
   PubMed Web of Science ®Google Scholar
• Kathuria N, Kraynyak KA, Carnathan D, Betts M, Weiner DB, Kutzler MA. Generation of antigen-specific immunity following systemic immunization with DNA vaccine encoding CCL25 chemokine immunoadjuvant. Hum Vaccin Immunother 2012; 8:1607-19; PMID:23151454; http://dx.doi.org/10.4161/hv.22574
   PubMed Web of Science ®Google Scholar
• Tan X, Sande JL, Pufnock JS, Blattman JN, Greenberg PD. Retinoic acid as a vaccine adjuvant enhances CD8+ T cell response and mucosal protection from viral challenge. J Virol 2011; 85:8316-27; PMID:21653670; http://dx.doi.org/10.1128/JVI.00781-11
   PubMed Web of Science ®Google Scholar
• Marchioro SB, Maes D, Flahou B, Pasmans F, Del PSR, Vranckx K, Melkebeek V, Cox E, Wuyts N, Haesebrouck F. Local and systemic immune responses in pigs intramuscularly injected with an inactivated Mycoplasma hyopneumoniae vaccine. Vaccine 2013; 31:1305-11; PMID:23306368; http://dx.doi.org/10.1016/j.vaccine.2012.12.068
   PubMed Web of Science ®Google Scholar
• Patel V, Valentin A, Kulkarni V, Rosati M, Bergamaschi C, Jalah R, Alicea C, Minang JT, Trivett MT, Ohlen C, et al. Long-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization. Vaccine 2010; 28:4827-36; PMID:20451642; http://dx.doi.org/10.1016/j.vaccine.2010.04.064
   PubMed Web of Science ®Google Scholar
• Schreckenberger C, Sethupathi P, Kanjanahaluethai A, Muller M, Zhou J, Gissmann L, Qiao L. Induction of an HPV 6bL1-specific mucosal IgA response by DNA immunization. Vaccine 2000; 19:227-33; PMID:10930677; http://dx.doi.org/10.1016/S0264-410X(00)00173-0
   PubMed Web of Science ®Google Scholar
• Hu MC, Jones T, Kenney RT, Barnard DL, Burt DS, Lowell GH. Intranasal Protollin-formulated recombinant SARS S-protein elicits respiratory and serum neutralizing antibodies and protection in mice. Vaccine 2007; 25:6334-40; PMID:17640780; http://dx.doi.org/10.1016/j.vaccine.2007.06.017
   PubMed Web of Science ®Google Scholar
• Corey L, Langenberg AG, Ashley R, Sekulovich RE, Izu AE, Douglas JJ, Handsfield HH, Warren T, Marr L, Tyring S, et al. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. JAMA 1999; 282:331-40; PMID:10432030; http://dx.doi.org/10.1001/jama.282.4.331
   PubMed Web of Science ®Google Scholar
• Belshe RB, Leone PA, Bernstein DI, Wald A, Levin MJ, Stapleton JT, Gorfinkel I, Morrow RL, Ewell MG, Stokes-Riner A, et al. Efficacy results of a trial of a herpes simplex vaccine. N Engl J Med 2012; 366:34-43; PMID:22216840; http://dx.doi.org/10.1056/NEJMoa1103151
   PubMed Web of Science ®Google Scholar
• Muszkat M, Greenbaum E, Ben-Yehuda A, Oster M, Yeu'L E, Heimann S, Levy R, Friedman G, Zakay-Rones Z. Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivated influenza vaccine. Vaccine 2003; 21:1180-6; PMID:12559796; http://dx.doi.org/10.1016/S0264-410X(02)00481-4
   PubMed Web of Science ®Google Scholar
• Lima FA, Miyaji EN, Quintilio W, Raw I, Ho PL, Oliveira ML. Pneumococcal Surface Protein A does not affect the immune responses to a combined diphtheria tetanus and pertussis vaccine in mice. Vaccine 2013; 31:2465-70; PMID:23541622; http://dx.doi.org/10.1016/j.vaccine.2013.03.026
   PubMed Web of Science ®Google Scholar
• Rioux G, Mathieu C, Russell A, Bolduc M, Laliberte-Gagne ME, Savard P, Leclerc D. PapMV nanoparticles improve mucosal immune responses to the trivalent inactivated flu vaccine. J Nanobiotechnology 2014; 12:19; PMID:24885884; http://dx.doi.org/10.1186/1477-3155-12-19
   PubMed Web of Science ®Google Scholar
• Jang SI, Lillehoj HS, Lee SH, Lee KW, Lillehoj EP, Bertrand F, Dupuis L, Deville S. Montanide IMS 1313 N VG PR nanoparticle adjuvant enhances antigen-specific immune responses to profilin following mucosal vaccination against Eimeria acervulina. Vet Parasitol 2011; 182:163-70; PMID:21700391; http://dx.doi.org/10.1016/j.vetpar.2011.05.019
   PubMed Web of Science ®Google Scholar
• Yang GB, Wang Y, Babaahmady K, Scholler J, Rahman D, Bunnik E, Spallek R, Zong CM, Duan JZ, Qin C, et al. Immunization with recombinant macaque major histocompatibility complex class I and II and human immunodeficiency virus gp140 inhibits simian-human immunodeficiency virus infection in macaques. J Gen Virol 2012; 93:1506-18; PMID:22492918; http://dx.doi.org/10.1099/vir.0.041061-0
   PubMed Web of Science ®Google Scholar
• Hagglund S, Hu K, Vargmar K, Pore L, Olofson AS, Blodorn K, Anderson J, Ahooghalandari P, Pringle J, Taylor G, et al. Bovine respiratory syncytial virus ISCOMs-Immunity, protection and safety in young conventional calves. Vaccine 2011; 29:8719-30; PMID:21864616; http://dx.doi.org/10.1016/j.vaccine.2011.07.146
   PubMed Web of Science ®Google Scholar
• Hammerschmidt SI, Friedrichsen M, Boelter J, Lyszkiewicz M, Kremmer E, Pabst O, Forster R. Retinoic acid induces homing of protective T and B cells to the gut after subcutaneous immunization in mice. J Clin Invest 2011; 121:3051-61; PMID:21737878; http://dx.doi.org/10.1172/JCI44262
   PubMed Web of Science ®Google Scholar
• Budimir N, de Haan A, Meijerhof T, Gostick E, Price DA, Huckriede A, Wilschut J. Heterosubtypic cross-protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administration. Influenza Other Respir Viruses 2013; 7:1202-9; PMID:24102979; http://dx.doi.org/10.1111/irv.12142
   PubMed Web of Science ®Google Scholar
• Wolf AI, Mozdzanowska K, Williams KL, Singer D, Richter M, Hoffmann R, Caton AJ, Otvos L, Erikson J. Vaccination with M2e-based multiple antigenic peptides: characterization of the B cell response and protection efficacy in inbred and outbred mice. Plos One 2011; 6:e28445;
   PubMed Web of Science ®Google Scholar
• Zhang XH, He KW, Zhang SX, Lu WC, Zhao PD, Luan XT, Ye Q, Wen LB, Li B, Guo RL, et al. Subcutaneous and intranasal immunization with Stx2B-Tir-Stx1B-Zot reduces colonization and shedding of Escherichia coli O157:H7 in mice. Vaccine 2011; 29:3923-9; PMID:21338683; http://dx.doi.org/10.1016/j.vaccine.2011.02.007
   PubMed Web of Science ®Google Scholar
• Babiuk S, Asper DJ, Rogan D, Mutwiri GK, Potter AA. Subcutaneous and intranasal immunization with type III secreted proteins can prevent colonization and shedding of Escherichia coli O157:H7 in mice. Microb Pathog 2008; 45:7-11; PMID:18487034; http://dx.doi.org/10.1016/j.micpath.2008.01.005
   PubMed Web of Science ®Google Scholar
• Fan HY, Wang L, Luo J, Long BG. Protection against Escherichia coli O157:H7 challenge by immunization of mice with purified Tir proteins. Mol Biol Rep 2012; 39:989-97; PMID:21567195; http://dx.doi.org/10.1007/s11033-011-0824-0
   PubMed Web of Science ®Google Scholar
• Herve PL, Raliou M, Bourdieu C, Dubuquoy C, Petit-Camurdan A, Bertho N, Eleouet JF, Chevalier C, Riffault S. A novel subnucleocapsid nanoplatform for mucosal vaccination against influenza virus that targets the ectodomain of matrix protein 2. J Virol 2014; 88:325-38; PMID:24155388; http://dx.doi.org/10.1128/JVI.01141-13
   PubMed Web of Science ®Google Scholar
• Cheng C, Pal S, Bettahi I, Oxford KL, Barry PA, de la Maza LM. Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate model. Vaccine 2011; 29:3456-64; PMID:21376796; http://dx.doi.org/10.1016/j.vaccine.2011.02.057
   PubMed Web of Science ®Google Scholar
• Krejci J, Nechvatalova K, Kudlackova H, Leva L, Bernardy J, Toman M, Faldyna M. Effects of adjuvants on the immune response of pigs after intradermal administration of antigen. Res Vet Sci 2013; 94:73-6; PMID:22929313; http://dx.doi.org/10.1016/j.rvsc.2012.07.021
   PubMed Web of Science ®Google Scholar
• Locher CP, Witt SA, Ashlock BM, Levy JA. Evaluation of genetic immunization adjuvants to improve the effectiveness of a human immunodeficiency virus type 2 (HIV-2) envelope DNA vaccine. DNA Cell Biol 2004; 23:107-10; PMID:15000750; http://dx.doi.org/10.1089/104454904322759911
   PubMed Web of Science ®Google Scholar
• Martelli P, Saleri R, Cavalli V, De Angelis E, Ferrari L, Benetti M, Ferrarini G, Merialdi G, Borghetti P. Systemic and local immune response in pigs intradermally and intramuscularly injected with inactivated Mycoplasma hyopneumoniae vaccines. Vet Microbiol 2014; 168:357-64; PMID:24332702; http://dx.doi.org/10.1016/j.vetmic.2013.11.025
   PubMed Web of Science ®Google Scholar
• Sanchez AE, Aquino G, Ostoa-Saloma P, Laclette JP, Rocha-Zavaleta L. Cholera toxin B-subunit gene enhances mucosal immunoglobulin A, Th1-type, and CD8+ cytotoxic responses when coadministered intradermally with a DNA vaccine. Clin Diagn Lab Immunol 2004; 11:711-9; PMID:15242946
   PubMedGoogle Scholar
• Naz RK. Effect of sperm DNA vaccine on fertility of female mice. Mol Reprod Dev 2006; 73:918-28; PMID:16596628; http://dx.doi.org/10.1002/mrd.20487
   PubMed Web of Science ®Google Scholar
• Schautteet K, De Clercq E, Jonsson Y, Lagae S, Chiers K, Cox E, Vanrompay D. Protection of pigs against genital Chlamydia trachomatis challenge by parenteral or mucosal DNA immunization. Vaccine 2012; 30:2869-81; PMID:22387629; http://dx.doi.org/10.1016/j.vaccine.2012.02.044
   PubMed Web of Science ®Google Scholar
• Sullivan SP, Koutsonanos DG, Del PMM, Lee JW, Zarnitsyn V, Choi SO, Murthy N, Compans RW, Skountzou I, Prausnitz MR. Dissolving polymer microneedle patches for influenza vaccination. Nat Med 2010; 16:915-20; PMID:20639891; http://dx.doi.org/10.1038/nm.2182
   PubMed Web of Science ®Google Scholar
• Heine SJ, Diaz-McNair J, Andar AU, Drachenberg CB, van de Verg L, Walker R, Picking WL, Pasetti MF. Intradermal delivery of Shigella IpaB and IpaD type III secretion proteins: kinetics of cell recruitment and antigen uptake, mucosal and systemic immunity, and protection across serotypes. J Immunol 2014; 192:1630-40; PMID:24453241; http://dx.doi.org/10.4049/jimmunol.1302743
   PubMed Web of Science ®Google Scholar
• Horner AA, Ronaghy A, Cheng PM, Nguyen MD, Cho HJ, Broide D, Raz E. Immunostimulatory DNA is a potent mucosal adjuvant. Cell Immunol 1998; 190:77-82; PMID:9826449; http://dx.doi.org/10.1006/cimm.1998.1400
   PubMed Web of Science ®Google Scholar
• Choi AH, Knowlton DR, McNeal MM, Ward RL. Particle bombardment-mediated DNA vaccination with rotavirus VP6 induces high levels of serum rotavirus IgG but fails to protect mice against challenge. Virology 1997; 232:129-38; PMID:9185596; http://dx.doi.org/10.1006/viro.1997.8552
   PubMed Web of Science ®Google Scholar
• Bal SM, Slutter B, Verheul R, Bouwstra JA, Jiskoot W. Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: adjuvant- and site-dependent immunogenicity in mice. Eur J Pharm Sci 2012; 45:475-81; PMID:22009113; http://dx.doi.org/10.1016/j.ejps.2011.10.003
   PubMed Web of Science ®Google Scholar
• Glenn GM, Scharton-Kersten T, Vassell R, Mallett CP, Hale TL, Alving CR. Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge. J Immunol 1998; 161:3211-4; PMID:9759833
   PubMed Web of Science ®Google Scholar
• Hickey DK, Aldwell FE, Tan ZY, Bao S, Beagley KW. Transcutaneous immunization with novel lipid-based adjuvants induces protection against gastric Helicobacter pylori infection. Vaccine 2009; 27:6983-90; PMID:19800441; http://dx.doi.org/10.1016/j.vaccine.2009.09.078
   PubMed Web of Science ®Google Scholar
• Heckert RA, Elankumaran S, Oshop GL, Vakharia VN. A novel transcutaneous plasmid-dimethylsulfoxide delivery technique for avian nucleic acid immunization. Vet Immunol Immunopathol 2002; 89:67-81; PMID:12208052; http://dx.doi.org/10.1016/S0165-2427(02)00186-1
   PubMed Web of Science ®Google Scholar
• Martin MP, Seth S, Koutsonanos DG, Jacob J, Compans RW, Skountzou I. Adjuvanted influenza vaccine administered intradermally elicits robust long-term immune responses that confer protection from lethal challenge. Plos One 2010; 5:e10897; PMID:20531947; http://dx.doi.org/10.1371/journal.pone.0010897
   PubMedGoogle Scholar
• Rollenhagen JE, Kalsy A, Cerda F, John M, Harris JB, Larocque RC, Qadri F, Calderwood SB, Taylor RK, Ryan ET. Transcutaneous immunization with toxin-coregulated pilin A induces protective immunity against Vibrio cholerae O1 El Tor challenge in mice. Infect Immun 2006; 74:5834-9; PMID:16988262; http://dx.doi.org/10.1128/IAI.00438-06
   PubMed Web of Science ®Google Scholar
• Berry LJ, Hickey DK, Skelding KA, Bao S, Rendina AM, Hansbro PM, Gockel CM, Beagley KW. Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection. Infect Immun 2004; 72:1019-28; PMID:14742549; http://dx.doi.org/10.1128/IAI.72.2.1019-1028.2004
   PubMed Web of Science ®Google Scholar
• Chen D, Periwal SB, Larrivee K, Zuleger C, Erickson CA, Endres RL, Payne LG. Serum and mucosal immune responses to an inactivated influenza virus vaccine induced by epidermal powder immunization. J Virol 2001; 75:7956-65; PMID:11483740; http://dx.doi.org/10.1128/JVI.75.17.7956-7965.2001
   PubMed Web of Science ®Google Scholar
• Gockel CM, Bao S, Beagley KW. Transcutaneous immunization induces mucosal and systemic immunity: a potent method for targeting immunity to the female reproductive tract. Mol Immunol 2000; 37:537-44; PMID:11163403; http://dx.doi.org/10.1016/S0161-5890(00)00074-2
   PubMed Web of Science ®Google Scholar
• John M, Bridges EA, Miller AO, Calderwood SB, Ryan ET. Comparison of mucosal and systemic humoral immune responses after transcutaneous and oral immunization strategies. Vaccine 2002; 20:2720-6; PMID:12034098; http://dx.doi.org/10.1016/S0264-410X(02)00208-6
   PubMed Web of Science ®Google Scholar
• Liard C, Munier S, Arias M, Joulin-Giet A, Bonduelle O, Duffy D, Shattock RJ, Verrier B, Combadiere B. Targeting of HIV-p24 particle-based vaccine into differential skin layers induces distinct arms of the immune responses. Vaccine 2011; 29:6379-91; PMID:21554912; http://dx.doi.org/10.1016/j.vaccine.2011.04.080
   PubMed Web of Science ®Google Scholar
• Rollenhagen JE, Kalsy A, Saksena R, Sheikh A, Alam MM, Qadri F, Calderwood SB, Kovac P, Ryan ET. Transcutaneous immunization with a synthetic hexasaccharide-protein conjugate induces anti-Vibrio cholerae lipopolysaccharide responses in mice. Vaccine 2009; 27:4917-22; PMID:19563890; http://dx.doi.org/10.1016/j.vaccine.2009.06.040
   PubMed Web of Science ®Google Scholar
• McKenzie R, Bourgeois AL, Frech SA, Flyer DC, Bloom A, Kazempour K, Glenn GM. Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study. Vaccine 2007; 25:3684-91; PMID:17313998; http://dx.doi.org/10.1016/j.vaccine.2007.01.043
   PubMed Web of Science ®Google Scholar
• Hansen S, Lehr CM. Nanoparticles for transcutaneous vaccination. Microb Biotechnol 2012; 5:156-67; PMID:21854553; http://dx.doi.org/10.1111/j.1751-7915.2011.00284.x
   PubMed Web of Science ®Google Scholar
• Suh H, Shin J, Kim YC. Microneedle patches for vaccine delivery. Clin Exp Vaccine Res 2014; 3:42-9; PMID:24427762; http://dx.doi.org/10.7774/cevr.2014.3.1.42
   PubMedGoogle Scholar
• Kim YC, Park JH, Prausnitz MR. Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev 2012; 64:1547-68; PMID:22575858; http://dx.doi.org/10.1016/j.addr.2012.04.005
   PubMed Web of Science ®Google Scholar
• Chang SY, Cha HR, Igarashi O, Rennert PD, Kissenpfennig A, Malissen B, Nanno M, Kiyono H, Kweon MN. Cutting edge: Langerin+ dendritic cells in the mesenteric lymph node set the stage for skin and gut immune system cross-talk. J Immunol 2008; 180:4361-5; PMID:18354155; http://dx.doi.org/10.4049/jimmunol.180.7.4361
   PubMed Web of Science ®Google Scholar
• Enioutina EY, Visic D, Daynes RA. The induction of systemic and mucosal immune responses to antigen-adjuvant compositions administered into the skin: alterations in the migratory properties of dendritic cells appears to be important for stimulating mucosal immunity. Vaccine 2000; 18:2753-67; PMID:10781863; http://dx.doi.org/10.1016/S0264-410X(00)00059-1
   PubMed Web of Science ®Google Scholar
• Belyakov IM, Hammond SA, Ahlers JD, Glenn GM, Berzofsky JA. Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells. J Clin Invest 2004; 113:998-1007; PMID:15057306; http://dx.doi.org/10.1172/JCI20261
   PubMed Web of Science ®Google Scholar
• Beagley KW, Eldridge JH, Lee F, Kiyono H, Everson MP, Koopman WJ, Hirano T, Kishimoto T, McGhee JR. Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells. J Exp Med 1989; 169:2133-48; PMID:2786548; http://dx.doi.org/10.1084/jem.169.6.2133
   PubMed Web of Science ®Google Scholar
• Corthesy B. Role of secretory IgA in infection and maintenance of homeostasis. Autoimmun Rev 2013; 12:661-5; PMID:23201924; http://dx.doi.org/10.1016/j.autrev.2012.10.012
   PubMed Web of Science ®Google Scholar
• Park CO, Kupper TS. The emerging role of resident memory T cells in protective immunity and inflammatory disease. Nat Med 2015; 21:688-97; PMID:26121195; http://dx.doi.org/10.1038/nm.3883
   PubMed Web of Science ®Google Scholar